Загрузка...
Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are often recommended as part of combination therapy for type 2 diabetes when oral medication does not result in sufficient glycemic control. Several GLP-1 receptor agonists are available as weekly injections. These medications vary in th...
Сохранить в:
| Опубликовано в: : | BMC Health Serv Res |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5702146/ https://ncbi.nlm.nih.gov/pubmed/29178918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2648-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|